New Delhi, Nov. 16 -- Glenmark Pharmaceuticals Q2 Results 2024:Glenmark Pharmaceuticals declared its Q2 results on 14 Nov, 2024, reporting a significant turnaround with a profit of Rs.354.21 crore. This is a remarkable recovery from the loss of Rs.81.95 crore recorded in the same period last fiscal year. Additionally, the company's topline increased by 7.06% year-on-year.

In comparison to the previous quarter, Glenmark's revenue showed a growth of 5.84%. However, there was a rise in selling, general, and administrative expenses, which increased by 10.72% quarter-on-quarter and 7.33% year-on-year.

The operating income also reflected positive growth, up by 2.38% from the last quarter and an astonishing 10,588.55% year-on-year increase. Th...